• Abstract Title: Titles should read as you want them to appear in meeting publications. Use title case capitalization, do not use all CAPITAL LETTERS and do not put a period at the end of the title. Example: This is a Properly Formatted Abstract Title

• Presentation Preference: Please note whether the preferred format is an oral presentation, e-poster or both. Note: This selection indicates your preferred choice and is not a guarantee.

• Presenting Author (First Author): Individual submitting the abstract
  • The Presenting Author is required to register and attend the meeting.
  • The Presenting Author is expected to present.
  • The Presenting Author must submit under one’s own account.
  • The Presenting Author’s account information/status (at the time of submission) is used to determine award eligibility.
  • All correspondence with the Presenting Author is done via email.

• Co-Authors: List full names with credentials and email addresses. All co-authors must be added to an abstract submission by November 5, 2024, at 5 pm CT and cannot be added post-acceptance.

• Abstract Topic Categories: Cerebrovascular, History, Pain, Pediatrics, Spine, Peripheral Nerve, Socioeconomic, Stereotactic and Functional, Trauma and Critical Care, Tumor.

• Abstract Body: Include introduction, methods, results and conclusion sections. Text is limited to 300 words.

• Additional Information: This includes elements such as previous presentation of the abstract, FDA approval, industry employment status, medical student/resident designation, senior author information, funding/database questions and award consideration. Note: Check the appropriate box(es) to be considered for awards.

• Disclosure: Disclosure is required for the presenting author, as well as agreement with the Terms and Conditions.

• Review Work: You may review your abstract by pressing “Preview Abstract.”
  • Please proofread before submission to avoid errors. 

• Submit: All tasks must be completed, and the abstract status must read “COMPLETE” on the submission site home screen for the abstract to be included in grading. A confirmation email will be sent.

Note: Abstracts cannot contain advertising, trade names or product-group messaging. Include generic names or terms in your abstract content. If the abstract includes trade names, names from several companies should be used — not just trade names from a single company — to present all available treatment options. If trade names or company names are included in your abstract, the AANS reserves the right to remove them to ensure all scientific content is free from commercial bias.